University of Ioannina
Μελέτη του ρόλου του κυτταροστατικού παράγοντα Εmi2 στη ρύθμιση του κυτταρικού κύκλου των ωοκυττάρων και των προεμφυτευτικών εμβρύων των θηλαστικών
Abstract
dc:descriptionMammalian oocytes enter meiosis before birth, where they remain arrested at G2/Prophase. Thus, oocytes may lie dormant in the ovary for many years (>40 in humans) until they receive the stimulus to grow and enter the first meiotic M-phase (MI). MI exit requires the proteolytic degradation of cyclin B1 through the action of the E3 ubiquitin ligase Anaphase Promoting Complex / Cyclosome (APC/C) and the subsequent inactivation of cyclin B1/Cdk1. Immediately after the first meiotic division, the oocyte enters the second meiotic M-phase and arrests at Metaphase II (MII) awaiting fertilization. MII arrest is maintained by the Cytostatic Factor activity (CSF) which inhibits the APC/C. CSF involves the Mos/MAPK pathway and the oocyte-specific APC/C inhibitor Emi2 (also known as Fbxo43). Emi2 is the final target of a cascade of events initiated by the oocyte-specific Mos kinase. Mos drives MAPK activation which leads to Emi2 phosphorylation and activation. At fertilization, the sperm introduces into the oocyte the phospholipase PLCζ which enables Emi2 degradation. Emi2 destruction releases the APC/C which then drives cyclin B1 degradation, leading to cyclin B1/Cdk1 inactivation followed by chromatid segregation and completion of meiosis. However, it is not known when Emi2 is first expressed and how it is regulated prior to MII arrest. Prior to MII, MI progression is regulated by the Spindle Assembly Checkpoint (SAC). Both in MI and mitosis, the SAC operates physiologically to inhibit the APC/C so that anaphase onset is delayed until all chromosomes are under tension on the M-phase spindle. Misaligned chromosomes cause the activation of the checkpoint and the delay or inhibition of cell division. Our study aims to investigate whether Emi2 functions as a general surveillance factor that may arrest oocytes in M-phase when the spindle is damaged. In addition, we examine whether Emi2 possesses an M-phase-independent role, in regulating G2/Prophase arrest. Finally, we examine if Emi2 is expressed in cleavage embryos and whether Emi2 can prevent mitotic exit in somatic cells. Firstly, we tested whether arrest in MI due to spindle damage shows characteristics of CSF. To verify that MI arrest possesses CSF characteristics, we manipulated the activity of CSF regulators, such as SrCl2, MAPK and CaMKII. We find that inhibition of MAPK, alleviated spindle damage-induced arrest in MI. When we introduce a constitutively active form of CaMKII into Taxol-arrested MI oocytes, the oocytes are relived from the state of arrest. These results show that MI arrest in mouse oocytes is regulated in a CSF-like manner, similar to MII-arrested oocytes. The cytostatic factor Emi2 is the major regulator of CSF in MII-arrested vertebrate oocytes. Therefore, we examined whether Emi2 is responsible for establishing a CSF state of arrest in MI following a SAC-induced MI arrest. In the presence of nocodazole or taxol, mouse oocytes arrest in the first meiotic M phase. However, the SAC-induced robust MI arrest is disrupted when Emi2 is absent. The fragmentation phenotype, decondensed chromatin, and micronuclei/pronuclei formation observed in Emi2-depleted oocytes, were major indicators of cyclin B1/Cdk1 inactivation. In order to test if this phenotype is due to cyclin B1/Cdk1 inactivation we examined the state of APC/C activity by evaluating the expressionand degradation of M phase APC/C substrates such as Geminin and Securin. These experiments show that in the absence of Emi2, MI arrested oocytes lose their ability to contain APC/C activity at low levels, thus eventually allowing exit from the state of arrest. Then we proceeded to examine SAC activity in mouse oocytes arrested at MI. Based on our results, although the SAC is fully capable of launching the M phase checkpoint in MI, it is not sufficient to maintain MI arrest in the absence of Emi2. Emi2 is responsible for counterbalancing the weakening of the SAC and, thus, allows the maintenance of MI arrest. In the absence of Emi2, the gradual weakening of the SAC may lead to full APC/C activity and exit from MI.To establish further the ability of Emi2 to maintain MI arrest, we examined whether Emi2 is efficient in supporting a state of M-phase arrest in the absence of M-phase checkpoint inducing mechanisms. We overexpressed a GFP version of Emi2 into mouse oocytes and released them into M-phase. We found that Emi2 overexpression causes MI arrest in mouse oocytes while the chromosomes are properly aligned. The fact that overexpressed Emi2 is localized on spindle microtubules interacting with chromosomes is an indication that Emi2 may be primarily focused on silencing the APC/C at the spindle/chromosome area. We also found no evidence of SAC presence in Emi2-arrested oocytes. Thus, Emi2 alone is sufficient to cause MI arrest in mouse oocytes. Therefore, we examined whether Emi2-dependent MI arrest is subject to the same regulatory mechanisms as MII arrest. We find that inhibition of MAPK and inhibition of PP2A leads to degradation of Emi2. Inhibition of PP2A has a dramatic effect on Emi2 stability and inhibition of MAPK also drives Emi2-GFP degradation in MI, but at a slower pace. Therefore, as in CSF-induced MII arrest, MI oocyte activation leads to Emi2 degradation and subsequently exit from M phase arrest. Our results show that Emi2 is a major regulator of MI progression, by maintaining the M-phase checkpoint in response to spindle disruption.Premature menopause and exhaustion of the oocyte reserve can occur if oocytes exit G2/Prophase arrest spontaneously. We find that Emi2 possesses, an M-phase-independent role, in regulating G2/Prophase arrest. When Emi2 is depleted in mouse oocytes, the oocytes can spontaneously exit the state of arrest and enter MI. Furthermore, overexpression of Emi2 in mouse oocytes prohibits the physiological progression of oocytes into the first meiotic M-phase and oocytes remain arrested at G2/Prophase. Interestingly, we find that exogenous Emi2-GFP is localized in the nucleus of G2/Prophase oocytes. It is the first time that Emi2 shows a nuclear localization. Therefore, Emi2 is not only an M-phase exit regulator. Our results show that Emi2 regulates the nuclear APC/C activity to control G2/Prophase arrest and progression into M-phase. We then proceeded to establish whether Emi2 possesses a role in the cell cycle of somatic cells. First, we examined if Emi2 is expressed in mitotic 2-cell or 4-cell embryos. There was no evidence that Emi2 is expressed in these preimplantation embryo stages. Furthermore, we addressed whether Emi2 can prevent mitotic exit in somatic cells. Firstly, we successfully established FACS analysis protocols for monitoring cell cycle dynamics in somatic cells transfected with an Emi2-GFP plasmid. In HEK293 and HeLa cell lines, overexpression of Emi2 appears to lead to arrest in the G2/M phases of the cell cycle. Emi2 may act as a cytostatic factor in somatic cells, as exogenous introduction of Emi2 significantly slowed cell proliferation. Therefore, there is a significant delay as Emi2-expressing cells attempt to pass through G2/M phases of the cell cycle. Confocal imaging experiments imply that Emi2 expression leads to a delay or arrest at the G2 phase of the cell cycle.. The slower proliferation of cells expressing Emi2 may be due to a delayed passing through the G2 phase of the cell cycle. Our results in somatic cells show that Emi2 can act as a cytostatic factor in cycling cells since the exogenous introduction of Emi2 slows down significantly cell proliferation. These exciting results may prove to be beneficial for cancer treatment.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Niaka, Konstantina
- Νιάκα, Κωνσταντίνα
Subjects
dc:subject × 8Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/52405